|
|
|
|
|
A phase III study comparing concurrent gemcitabine (Gem) plus cisplatin (Cis) and radiation followed by adjuvant Gem plus Cis versus concurrent Cis and radiation in patients with stage IIB to IVA carcinoma of the cervix |
2552 |
# |
|
|
|
|
|
A PHASE IIA, OPEN-LABEL STUDY TO ASSESS THE ANTIVIRAL ACTIVITY OF TMC435 MONOTHERAPY IN PATIENTS INFECTED WITH HCV GENOTYPES 2-6 |
2553 |
# |
|
|
|
|
|
A phase II study to evaluate WF10 in patients with late hemorrhagic radiation cystitis and proctitis. |
2549 |
# |
|
|
|
|
|
A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma. |
2562 |
# |
|
|
|
|
|
A phase II study of the combination of gemcitabine plus carboplatin as the neoadjuvant treatment in locally advanced breast cancer |
2556 |
# |
|
|
|
|
|
A phase II randomized trial of amphotericin B alone or combined with fluconazole in the treatment of HIV-associated cryptococcal meningitis |
2552 |
# |
|
|
|
|
|
A Phase II Open-label Pilot Study of the Safety, Pharmacokinetics and Antiviral Activity of BIT225, a HCV p7 inhibitor, in Combination with Pegylated Interferon and Ribavirin in Patients with HCV Genotypes 1 and 3 who are Co-infected with HIV-1 |
2556 |
# |
|
|
|
|
|
A Phase II Open-label Pilot Study of the Safety, Pharmacokinetics and Antiviral Activity of BIT225, a HCV p7 inhibitor, in Combination with Pegylated Interferon and Ribavirin in Patients with HCV Genotypes 1 and 3 who are Co-infected with HIV-1 |
2556 |
# |
|
|
|
|
|
A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia. |
2563 |
# |
|
|
|
|
|
A phase 2 study of the safety, tolerability, and pharmacodynamics of FBS0701, a novel oral iron chelator, in transfusional iron overload |
2555 |
# |
|
|
|
|
|
A phase 2 randomized controlled dose-ranging trial of recombinant pertussis booster vaccines containing genetically inactivated pertussis toxin in women of childbearing age |
2564 |
# |
|
|
|
|
|
A Phase 1b/2a study of the safety, pharmacokinetics and antiviral activity of BIT225 in patients with HIV-1 infection |
2559 |
# |
|
|
|
|
|
A Phase 1B Dose-Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of FBS0701, a Novel Oral Iron Chelator for the Treatment of Chronic Iron Overload. |
2553 |
# |
|
|
|
|
|
A phase 1/2 comparative vaccine trial of the safety and immunogenicity of a CRF01_AE (subtype E) candidate vaccine: ALVAC-HIV (vCP1521) prime with oligomeric gp160 (92TH023/LAI-DID) or bivalent gp120 (CM235/SF2) boost. |
2550 |
# |
|
|
|
|
|
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Multiple, Intravenous, Ascending-Dose Study of Sirukumab in Patients with Cutaneous or Systemic Lupus Erythematosus. |
2554 |
# |
|
|
|
|
|
A peptide inhibitor derived from the conserved ectodomain region of DENV membrane (M) protein with activity against Dengue virus infection. |
2558 |
# |
|
|
|
|
|
A patient-centric approach to optimise insulin therapy in Asia |
2559 |
# |
|
|
|
|
|
A paradigm shift on beta-thalassaemia treatment: How will we manage this old disease with new therapies? |
2561 |
# |
|
|
|
|
|
A One Health approach to assessing occupational exposure to antimicrobial resistance in Thailand: The FarmResist project |
2564 |
# |
|
|
|
|
|
A nuclear targeting system in Plasmodium falciparum |
2553 |
# |
|
|
|
|
|
A Novel, Inexpensive In-House Immunochromatographic Strip Test for Cryptococcosis Based on the Cryptococcal Glucuronoxylomannan Specific Monoclonal Antibody 18B7 |
2564 |
# |
|
|
|
|
|
A novel TRPM7/O-GlcNAc axis mediates tumour cell motility and metastasis by stabilising c-Myc and caveolin-1 in lung carcinoma |
2563 |
# |
|
|
|
|
|
A novel technique of aluminum multiplier slide culture for fungal identification |
2561 |
# |
|
|
|
|
|
A novel technique for endoscopic ultrasound-guided biliary drainage |
2556 |
# |
|
|
|
|
|
A novel structure of Tn4001-truncated element, type V, in clinical enterococcal isolates and multiplex PCR for detecting aminoglycoside resistance genes. |
2551 |
# |
|
|
|
|
|
A novel strategy for dengue viruses to escape host immune surveillance and disseminate infection |
2561 |
# |
|
|
|
|
|
A novel strategy for complement evasion by nonstructural protein-1 of dengue virus |
2559 |
# |
|
|
|
|
|
A novel start codon mutation of the MERTK gene in a patient with retinitis pigmentosa |
2559 |
# |
|
|
|
|
|
A novel SR protein binding site in a cis-regulatory element of HIV-1 |
2553 |
# |
|
|
|
|
|
A Novel Sporadic 614-Kb Duplication of the 22q11.2 Chromosome in a Child With Amyoplasia |
2554 |
# |